G. Kelly
AstraZeneca (Brazil)(BR)
Publications by Year
Research Areas
Peptidase Inhibition and Analysis, Protease and Inhibitor Mechanisms, Antimicrobial Peptides and Activities, Blood Coagulation and Thrombosis Mechanisms, Chemical Synthesis and Analysis
Most-Cited Works
- → Polymeric prodrug combination to exploit the therapeutic potential of antimicrobial peptides against cancer cells(2016)36 cited
- → Vibrating Mesh Nebulisation of Pro-Antimicrobial Peptides for Use in Cystic Fibrosis(2019)17 cited
- → Ticarcillin-Induced Neutropenia Corroborated by in vitro CFU-C Toxicity(1983)13 cited
- → Using Disease-Associated Enzymes to Activate Antimicrobial Peptide Prodrugs(2016)6 cited
- → Quantitative and Qualitative Deficiency of T-Lymphocyte Colony Formation in T-Cell Lymphoma-Leukaemia(1983)3 cited
- → Depletion of T‐lymphocyte subsets using monoclonal antibody and complement: Effect on T‐colony formation(1984)1 cited
- → Effects of pig leukocytes on mouse lymphatic leukemia(1971)1 cited
- → PiSS Alpha-1 Antitrypsin Deficiency: A Clinical Risk Variant?(2023)1 cited
- → Correction(1979)
- → An Update from the Irish National Alpha-1 Antitrypsin Deficiency Targeted Detection Programme(2022)